(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.48%) $78.86
(0.32%) $2.20
(0.11%) $2 333.80
(0.20%) $27.67
(0.20%) $966.80
(0.02%) $0.928
(0.03%) $10.83
(0.02%) $0.796
(-0.01%) $91.34
3 days till quarter result
(amc 2024-05-09)
Expected move: +/- 7.96%
1.83% $ 13.88
@ $13.88
Wydano: 6 geg. 2024 @ 22:34
Zwrot: 0.04%
Poprzedni sygnał: geg. 6 - 21:57
Poprzedni sygnał:
Zwrot: 0.43 %
Live Chart Being Loaded With Signals
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells...
Stats | |
---|---|
Dzisiejszy wolumen | 4.73M |
Średni wolumen | 9.04M |
Kapitalizacja rynkowa | 3.88B |
EPS | $0 ( 2024-02-28 ) |
Następna data zysków | ( $-0.450 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.34 |
ATR14 | $0.499 (3.60%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Vogt Frederick G | Buy | 20 834 | Common Stock |
2024-04-15 | Vogt Frederick G | Sell | 8 851 | Common Stock |
2024-04-15 | Vogt Frederick G | Sell | 20 834 | Restricted Stock Units |
2024-04-15 | Graf Finckenstein Friedrich | Buy | 2 812 | Common Stock |
2024-04-15 | Graf Finckenstein Friedrich | Sell | 1 427 | Common Stock |
INSIDER POWER |
---|
94.67 |
Last 99 transactions |
Buy: 13 607 426 | Sell: 449 378 |
Wolumen Korelacja
Iovance Biotherapeutics Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
LRMR | 0.94 |
EQ | 0.933 |
CFLT | 0.924 |
POWL | 0.916 |
TARA | 0.914 |
MACK | 0.902 |
PXLW | 0.902 |
CLBT | 0.901 |
MEDP | 0.9 |
KTCC | 0.9 |
10 Najbardziej negatywne korelacje | |
---|---|
SSRM | -0.916 |
BLKB | -0.911 |
DCRC | -0.91 |
SGLB | -0.908 |
AMRB | -0.9 |
CAR | -0.886 |
BIOL | -0.878 |
WTER | -0.874 |
CYAN | -0.874 |
EGAN | -0.868 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Iovance Biotherapeutics Korelacja - Waluta/Towar
Iovance Biotherapeutics Finanse
Annual | 2023 |
Przychody: | $1.19M |
Zysk brutto: | $-31.94M (-2 686.12 %) |
EPS: | $-1.890 |
FY | 2023 |
Przychody: | $1.19M |
Zysk brutto: | $-31.94M (-2 686.12 %) |
EPS: | $-1.890 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-21.14M (0.00 %) |
EPS: | $-2.45 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.20 |
Financial Reports:
No articles found.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; and Novartis Pharma AG. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej